{
    "clinical_study": {
        "@rank": "51903", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Cortisone, Clemastin + BERINERT"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Cortinsone, Clemastin + NaCl"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is a randomized, double-blind, two arms, multicenter, Phase III study of Berinert\n      for treatment of ACE induced Angioedema.\n\n      This study should show that Berinert shortens the time to complete resolution of signs and\n      symptoms of acute ACE-induced angioedema of the upper airway tract compared to placebo when\n      given on top of standard treatment. This study should also compare the time to onset of\n      relief as defined by an at least one point reduction on the severity scale of ACE-induced\n      angioedema with Berinert versus placebo."
        }, 
        "brief_title": "Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute ACE-induced Angioedema", 
        "condition_browse": {
            "mesh_term": "Angioedema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent to participate in the study and ability to fulfil all study\n             requirements\n\n          -  Male or female patients aged >=18 years\n\n          -  Patients with ACE induced angioedema (grade II-III) with imminent airway obstruction\n             admitted to an Emergency department\n\n          -  Patient is being treated with ACEi\n\n          -  Patient must have acute angioedema attack caused by ACEi\n\n          -  Treatment should be administered within 10 hours after onset of the angioedema\n\n          -  Patients with angioedema of the head and/or neck (face, lips, cheeks, tongue, soft\n             palate/uvula, pharynx and larynx)\n\n          -  Male participants and female participants who are not capable of bearing children or\n             who use a method of contraception that is medically approved by the health authority\n             of the respective country\n\n          -  Signed patient information consent form\n\n        Exclusion Criteria:\n\n          -  Diagnosis of angioedema of other genesis: e.g. hereditary angioedema, C1-inhibitor\n             deficiency, allergic edema, anaphylaxis, insect bite, trauma, abscess, local\n             inflammation, local tumour, post-operative or post-radiogenic edema, salivary gland\n             disorders\n\n          -  Participation in a clinical study in the past 30 days\n\n          -  Patients with simultaneous itchiness of skin (acute urticaria)\n\n          -  Patients with a history of angioedema before taking ACEi\n\n          -  History of hypersensitivity to any of the study drugs or medicine with a similar\n             chemical structure.\n\n          -  Pregnancy and/or breastfeeding\n\n          -  Mental retardation of the patient with restriction of general judgment and awareness\n\n          -  History of drug abuse (including alcohol and alcoholic liver disorders)\n\n          -  Potentially unreliable patients\n\n          -  Patients who are not suitable for the study in the opinion of the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01843530", 
            "org_study_id": "BER-1272-0058-I"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 1", 
                "intervention_name": "Berinert", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group 1", 
                    "Group 2"
                ], 
                "intervention_name": "Clemastin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group 1", 
                    "Group 2"
                ], 
                "intervention_name": "Cortisone acetate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Group 2", 
                "intervention_name": "NaCl", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cortisone acetate", 
                "Cortisone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 4, 2014", 
        "location": [
            {
                "contact": {
                    "email": "ulrike.foerster@charite.de", 
                    "last_name": "Ulrike F\u00f6rster, Dr.", 
                    "phone": "+49 30450 655", 
                    "phone_ext": "227"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Charite, Universit\u00e4tsmedizin Berlin, Campus Virchow Kliniken"
                }, 
                "investigator": {
                    "last_name": "Ulrike F\u00f6rster, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "m.bas.hno@googlemail.com", 
                    "last_name": "Murat Bas, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "81675"
                    }, 
                    "name": "Klinikum rechts der Isar, Hals-Nasen-Ohren Klinik"
                }, 
                "investigator": {
                    "last_name": "Murat Bas, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "klaus.stelter@med.uni-muenchen.de", 
                    "last_name": "Klaus Stelter, Dr.", 
                    "phone": "+49 89 7095", 
                    "phone_ext": "3888"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "81377"
                    }, 
                    "name": "Ludwig-Maximilian-Universit\u00e4t"
                }, 
                "investigator": {
                    "last_name": "Klaus Stelter, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jens.greve@uniklinik-ulm.de", 
                    "last_name": "Jens Greve, Dr.", 
                    "phone": "+49 731 500", 
                    "phone_ext": "59501"
                }, 
                "contact_backup": {
                    "last_name": ", ."
                }, 
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89070"
                    }, 
                    "name": "Universit\u00e4tsklinikum Ulm, HNO"
                }, 
                "investigator": {
                    "last_name": "Jens Greve, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema", 
        "overall_contact": {
            "email": "beate.schossow@mri.tum.de", 
            "last_name": "Beate Schossow", 
            "phone": "+49(0)89 4140-5840"
        }, 
        "overall_official": {
            "affiliation": "Klinikum rechts der Isar", 
            "last_name": "Murat Bas, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Paul-Ehrlich-Institut", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Berinert shortens the time to complete resolution of signs and symptoms of acute ACE-induced angioedema of the upper airway tract compared to placebo when given on top of standard treatment.", 
            "measure": "time of resolution", 
            "safety_issue": "No", 
            "time_frame": "07/2013 until 12/2014"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01843530"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Technische Universit\u00e4t M\u00fcnchen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t M\u00fcnchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}